Interleukin-1alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain model

Pain

Volumn 138, Issue 3, 2008, Pages 587-597

  Mika, Joanna ^a   Korostynski, Michal ^a   Kaminska, Dorota ^a   Wawrzczak Bargiela, Agnieszka ^a   Osikowicz, Maria ^a   Makuch, Wioletta ^a   Przewlocki, Ryszard ^a   Przewlocka, Barbara ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

IL 1 receptor antagonist; IL 10; IL 1alpha; IL 1beta; IL 6; Neuropathic pain

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT INTERLEUKIN 1ALPHA; RECOMBINANT INTERLEUKIN 1BETA; ANALGESIC AGENT;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; GENE EXPRESSION; HYPERALGESIA; LUMBAR SPINAL CORD; MALE; MECHANICAL STIMULATION; MICROGLIA; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPINAL GANGLION; WESTERN BLOTTING; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; METABOLISM; METHODOLOGY; PAIN; PAIN ASSESSMENT; PHYSIOLOGY; WISTAR RAT;

ANALGESICS; ANIMALS; DISEASE MODELS, ANIMAL; GANGLIA, SPINAL; HYPERALGESIA; INTERLEUKIN-1ALPHA; MALE; PAIN; PAIN MEASUREMENT; RATS; RATS, WISTAR;

EID: 49349097493     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2008.02.015     Document Type: Article

References (61)

1. Anforth H.R., Bluthe R.M., Bristow A., Hopkins S., Lenczowski M.J., Luheshi G., et al. Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta. Eur Cytokine Netw 9 (1998) 279-288
2. Banks W.A., Kastin A.J., and Gutierrez E.G. Interleukin-1alpha in blood has direct access to cortical brain cells. Neurosci Lett 163 (1993) 41-44
3. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
4. Busbridge N.J., Dascombe M.J., Tilders F.J., van Oers J.W., Linton E.A., and Rothwell N.J. Central activation of thermogenesis and fever by interleukin-1 beta and interleukin-1 alpha involves different mechanisms. Biochem Biophys Res Commun 162 (1989) 591-596
5. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53 (1994) 55-63
6. Colburn R.W., DeLeo J.A., Rickman A.J., Yeager M.P., Kwon P., and Hickey W.F. Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J Neuroimmunol 79 (1997) 163-175
7. Coyle D.E. Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior. Glia 23 (1998) 75-83
8. DeLeo J.A., and Yezierski R.P. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90 (2001) 1-6
9. Devor M. Response to nerve injury in relation to neuropathic pain. In: McMahon S.B., and Koltzenburg M. (Eds). Wall and Melzack's textbook of pain. 5th ed. (2006), Elsevier Churchill Livingstone, London 905-927
10. Dorazil-Dudzik M., Mika J., Schafer M.K., Li Y., Obara I., Wordliczek J., and Przewlocka B. The effects of local pentoxifylline and propentofylline treatment on formalin-induced pain and tumor necrosis factor-alpha messenger RNA levels in the inflamed tissue of the rat paw. Anesth Analg 98 (2004) 1566-1573
11. Dower S.K., Kronheim S.R., March C.J., Conlon P.J., Hopp T.P., Gillis S., and Urdal D.L. Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. J Exp Med 162 (1985) 501-515
12. Flatters S.J., Fox A.J., and Dickenson A.H. Spinal interleukin-6 (IL-6) inhibits nociceptive transmission following neuropathy. Brain Res 984 (2003) 54-62
13. Giulian D., Baker T.J., Shih L.C., and Lachman L.B. Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med 164 (1986) 594-604
14. Guo W., Wang H., Watanabe M., Shimizu K., Zou S., LaGraize S.C., et al. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 27 (2007) 6006-6018
15. Gruol D.L., and Nelson T.E. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 15 (1997) 307-339
16. Gustafsson K., Sultana T., Zetterstrom C.K., Setchell B.P., Siddiqui A., Weber G., and Soder O. Production and secretion of interleukin-1alpha proteins by rat testis. Biochem Biophys Res Commun 297 (2002) 492-497
17. Hamilton T.A., Ohmori Y., Tebo J.M., and Kishore R. Regulation of macrophage gene expression by pro- and anti-inflammatory cytokines. Pathobiology 67 (1999) 241-244
18. Hanisch U.K. Microglia as a source and target of cytokines. Glia 40 (2002) 140-155
19. Hopkins S.J., and Rothwell N.J. Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci 18 (1995) 83-88
20. Huber T.S., Gaines G.C., Welborn MB 3r., Rosenberg J.J., Seeger J.M., and Moldawer L.L. Anticytokine therapies for acute inflammation and the systemic inflammatory response syndrome: IL-10 and ischemia/reperfusion injury as a new paradigm. Shock 13 (2000) 425-434
21. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19 (1996) 312-318
22. Labuz D., Berger S., Mousa S.A., Zollner C., Rittner H.L., Shaqura M.A., et al. Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain. J Neurosci 26 (2006) 4350-4358
23. Laughlin T.M., Bethea J.R., Yezierski R.P., and Wilcox G.L. Cytokine involvement in dynorphin-induced allodynia. Pain 84 (2000) 159-167
24. Ledeboer A., Sloane E.M., Milligan E.D., Frank M.G., Mahony J.H., Maier S.F., et al. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115 (2005) 71-83
25. Lee H.L., Lee K.M., Son S.J., Hwang S.H., and Cho H.J. Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model. Neuroreport 15 (2004) 2807-2811
26. Malcangio M., Bowery N.G., Flower R.J., and Perretti M. Effect of interleukin-1beta on the release of substance P from rat isolated spinal cord. Eur J Pharmacol 299 (1996) 113-118
27. Mika J., Osikowicz M., Makuch W., and Przewlocka B. Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. Eur J Pharmacol 560 (2007) 142-149
28. Milligan E.D., Langer S.J., Sloane E.M., He L., Wieseler-Frank J., O'Connor K., et al. Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci 21 (2005) 2136-2148
29. Milligan E.D., Twining C., Chacur M., Biedenkapp J., O'Connor K., Poole S., et al. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 23 (2003) 1026-1040
30. Mosley B., Urdal D.L., Prickett K.S., Larsen A., Cosman D., Conlon P.J., et al. The interleukin-1 receptor binds the human interleukin-1alpha precursor but not the interleukin-1beta precursor. J Biol Chem 262 (1987) 2941-2944
31. Nakajima K., and Kohsaka S. Microglia: activation and their significance in the central nervous system. J Biochem (Tokyo) 130 (2001) 169-175
32. Narita M., Yoshida T., Nakajima M., Narita M., Miyatake M., Takagi T., et al. Direct evidence for spinal cord microglia in the development of a neuropathic pain-like state in mice. J Neurochem 97 (2006) 1337-1348
33. Obreja O., Rathee P.K., Lips K.S., Distler C., and Kress M. IL-1beta potentiates heat-activated currents in rat sensory neurons:involvement of IL-1RI, tyrosine kinase, and protein kinase C. FASEB J 16 (2002) 1497-1503
34. Oka T., Aou S., and Hori T. Intracerebroventricular injection of interleukin-1beta induces hyperalgesia in rats. Brain Res 624 (1993) 61-68
35. Opree A., and Kress M. Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J Neurosci 20 (2000) 6289-6293
36. Piao Z.G., Cho I.H., Park C.K., Hong J.P., Choi S.Y., Lee S.J., et al. Activation of glia and microglial p38 MAPK in medullary dorsal horn contributes to tactile hypersensitivity following trigeminal sensory nerve injury. Pain 121 (2006) 219-231
37. Raghavendra V., Tanga F.Y., and DeLeo J.A. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci 20 (2004) 467-473
38. Relton J.K., and Rothwell N.J. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 29 (1992) 243-246
39. Rodriguez Parkitna J., Korostynski M., Kaminska-Chowaniec D., Obara I., Mika J., Przewlocka B., et al. Comparison of gene expression profiles in neuropathic and inflammatory pain. J Physiol Pharmacol 57 (2006) 401-414
40. Rothwell N.J. Neuroimmune interactions: the role of cytokines. Br J Pharmacol 121 (1997) 841-847
41. Satoh J., Kastrukoff L.F., and Kim S.U. Cytokine-induced expression of intercellular adhesion molecule-1 (ICAM-1) in cultured human oligodendrocytes and astrocytes. J Neuropathol Exp Neurol 50 (1991) 215-226
42. Sawada M., Suzumura A., Hosoya H., Marunouchi T., and Nagatsu T. Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia. J Neurochem 72 (1999) 1466-1471
43. Schafer M.K., Schwaeble W.J., Post C., Salvati P., Calabresi M., Sim R.B., et al. Complement C1q is dramatically up-regulated in brain microglia in response to transient global cerebral ischemia. J Immunol 164 (2000) 5446-5452
44. Schrijver H.M., Crusius J.B., Uitdehaag B.M., Garcia Gonzalez M.A., Kostense P.J., Polman C.H., et al. Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MS. Neurology 52 (1999) 595-599
45. Shavit Y., Wolf G., Goshen I., Livshits D., and Yirmiya R. Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance. Pain 115 (2005) 50-59
46. Sheng J.G., Mrak R.E., and Griffin W.S. Microglial interleukin-1alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Neuropathol Appl Neurobiol 21 (1995) 290-301
47. Sheng J.G., Mrak R.E., and Griffin W.S. Enlarged and phagocytic, but not primed, interleukin-1alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol (Berl) 95 (1998) 229-234
48. Sung C.S., Wen Z.H., Chang W.K., Ho S.T., Tsai S.K., Chang Y.C., et al. Intrathecal interleukin-1beta administration induces thermal hyperalgesia by activating inducible nitric oxide synthase expression in the rat spinal cord. Brain Res 1015 (2004) 145-153
49. Stoll G., and Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol 58 (1999) 233-247
50. Sweitzer S., Martin D., and DeLeo J.A. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 103 (2001) 529-539
51. Touzani O., Boutin H., Chuquet J., and Rothwell N. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroimmunol 100 (1999) 203-215
52. Vezzani A., Conti M., De Luigi A., Ravizza T., Moneta D., Marchesi F., et al. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 19 (1999) 5054-5065
53. Wang X.J., Kong K.M., Qi W.L., Ye W.L., and Song P.S. Interleukin-1beta induction of neuron apoptosis depends on p38 mitogen-activated protein kinase activity after spinal cord injury. Acta Pharmacol Sin 26 (2005) 934-942
54. Watkins L.R., and Maier S.F. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov 2 (2003) 973-985
55. Watkins L.R., Milligan E.D., and Maier S.F. Glial activation: a driving force for pathological pain. Trends Neurosci 24 (2001) 450-455
56. Watkins L.R., Milligan E.D., and Maier S.F. Spinal cord glia: new players in pain. Pain 93 (2001) 201-215
57. Winkelstein B.A., Rutkowski M.D., Sweitzer S.M., Pahl J.L., and DeLeo J.A. Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment. J Comp Neurol 439 (2001) 127-139
58. Wordliczek J., Szczepanik A.M., Banach M., Turchan J., Zembala M., Siedlar M., et al. The effect of pentoxifiline on post-injury hyperalgesia in rats and postoperative pain in patients. Life Sci 66 (2000) 1155-1164
59. Xu X.J., Hao J.X., Andell-Jonsson S., Poli V., Bartfai T., and Wiesenfeld-Hallin Z. Nociceptive responses in interleukin-6-deficient mice to peripheral inflammation and peripheral nerve section. Cytokine 9 (1997) 1028-1033
60. Yaksh T.L., and Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 17 (1976) 1031-1036
61. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110